Related Experiment Video
Updated: Jun 7, 2026
Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
Expression of human beta-defensins in children with chronic inflammatory bowel disease
Matthias Zilbauer1, Andreas Jenke, Gundula Wenzel
1Department of Paediatrics, HELIOS Klinikum Wuppertal, Germany. mz304@medschl.cam.ac.uk
Insights
Human beta-defensins (hBDs) show altered expression in pediatric inflammatory bowel disease (IBD). This study reveals distinct changes in hBD levels across the intestine, linking them to IBD pathogenesis in children.
Area of Science:
- Immunology
- Gastroenterology
- Pediatrics
Background:
- Human beta-defensins (hBDs) are key antimicrobial peptides in intestinal innate immunity.
- Altered hBD expression is implicated in inflammatory bowel disease (IBD) pathogenesis.
- Limited data exists on hBD expression in pediatric IBD.
Purpose of the Study:
- To investigate the expression patterns of hBD1-3 in the intestines of children with IBD.
- To correlate hBD expression with inflammatory markers in pediatric IBD.
- To understand the role of hBDs in pediatric IBD pathogenesis.
Main Methods:
- Intestinal biopsies collected from children with Crohn's disease, ulcerative colitis, and healthy controls.
- Quantitative real-time PCR (RT-PCR) used to analyze hBD1-3 mRNA levels.
- Analysis of inflammatory cytokines IL-8 and TNF-alpha mRNA expression.
Main Results:
- Significant induction of hBD2 and hBD3 observed in inflamed ileum and colon of IBD children.
- hBD2 induction in the colon was lower in Crohn's disease than ulcerative colitis.
- Strong correlation found between hBD2/hBD3 and IL-8/TNF-alpha in inflamed intestinal segments.
Conclusions:
- Distinct changes in hBD expression occur in the pediatric IBD intestinal tract.
- hBDs likely play a role in the pathogenesis of IBD in children.
- Further research into hBDs as therapeutic targets for pediatric IBD is warranted.
Background:
Human beta-defensins (hBDs) are antimicrobial peptides known to play a major role in intestinal innate host defence. Altered mucosal expression of hBDs has been suggested to be implicated in chronic inflammatory bowel disease pathogenesis. However, little is known about expression of these peptides in children.
Methods:
Intestinal biopsies were obtained from the duodenum (n = 88), terminal ileum (n = 90) and ascending colon (n = 105) of children with Crohn's disease (n = 26), ulcerative colitis (n = 11) and healthy controls (n = 16). Quantitative real-time (RT) PCR was performed and absolute mRNA copy numbers analyzed for hBD1-3 as well as inflammatory cytokines IL-8 and TNF-alpha.
Results:
Significant induction of hBD2 and hBD3 was observed in the inflamed terminal ileum and ascending colon of IBD children. In the ascending colon induction of hBD2 was found to be significantly lower in children with Crohn's disease compared to ulcerative colitis. A strong correlation was found between inducible defensins hBD2 and 3 and the inflammatory cytokines IL-8 and TNF-alpha, both in the terminal ileum and ascending colon.
Conclusion:
Our study demonstrates distinct changes in hBD expression throughout the intestinal tract of children with IBD, lending further support for their potential role in disease pathogenesis.
More Related Videos
08:37Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
08:50A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...